OTC · Biotechnology

Acrux Limited (ARUXF) Stock

$0.02 +0.00% OTC: ARUXF Healthcare

Acrux Limited, alongside its affiliated entities, specializes in the global development and commercialization of generic and topical pharmaceutical products. The company's reach extends across international markets, including Australia, Europe, and the United States.

Valuation

MetricValue
Price$0.02
Market Cap$6.78M
P/E Ratio-1.90
P/B Ratio3.76
P/S Ratio1.85
EPS (TTM)$-0.02
52-Week High$0.05
52-Week Low$0.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-211.88%
ROA-49.76%
ROCE-193.97%
Gross Margin56.94%
Operating Margin-185.41%
Net Margin-83.81%
Debt/Equity3.03
Current Ratio1.35

Annual Financials (USD)

Metric20212022202320242025
Revenue$1.0M$2.0M$8.0M$5.0M$1.0M
Operating Profit$-24.0M$-18.0M$-6.0M$-9.0M$-9.0M
Net Profit$-13.0M$-10.0M$-1.0M$-6.0M$-6.0M
EPS$-0.06$-0.03$0.00$-0.02$-0.02
Op Margin-1767.1%-1027.6%-70.1%-168.4%-754.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.0M$14.0M$13.0M$9.0M$7.0M
Total Liabilities$5.0M$5.0M$5.0M$6.0M$6.0M
Cash$15.0M$6.0M$6.0M$3.0M$1.0M
Borrowings$2.0M$2.0M$2.0M$4.0M$4.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-11.0M$-9.0M$1.0M$-4.0M$-5.0M
Investing Cash Flow$0$-1.0M$0$-1.0M$0
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$6.0M$-9.0M$0$-3.0M$-2.0M
Free Cash Flow$-12.0M$-9.0M$1.0M$-5.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.02
EV / EBITDA-1.70
FCF Yield-46.57%
Quick Ratio1.35
Interest Coverage-34.28
Return 1Y111.25%
Return 3Y-60.97%
Return 5Y—

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AGNPFGrey Matters Health Inc. $0.25 -17.12% -0.43 $869804 0.00%
AXIMAXIM Biotechnologies, Inc. $0.00 — -2.00 $1.02M 0.00%
HAVLFHAVN Life Sciences Inc. $0.00 — -0.01 $2565 0.00%
IBOGFUniversal Ibogaine Inc. $0.02 +6.82% -0.09 $7.35M 0.00%
PKTXProtoKinetix, Incorporated $0.00 — -1.00 $156632 0.00%

About Acrux Limited

Acrux Limited, alongside its affiliated entities, specializes in the global development and commercialization of generic and topical pharmaceutical products. The company's reach extends across international markets, including Australia, Europe, and the United States. A significant part of its offerings includes diverse testosterone therapies, available in various forms such as oral and buccal tablets, subcutaneous pellets, transdermal patches, injections, and topical gels, all aimed at treating adult men with low or absent testosterone levels. Additionally, Acrux provides estradiol sprays, sold under the brand names Evamist and Lenzetto, specifically formulated for women experiencing hot flashes associated with menopause. The company, established in 1998, is headquartered in West Melbourne, Australia.

Acrux Limited is headquartered in AU.

Acrux Limited (ARUXF) stock trades at $0.02 with a market capitalization of $6.78M. The stock is valued at a price-to-earnings (P/E) ratio of -1.90, price-to-book of 3.76, price-to-sales of 1.85. Over the past 52 weeks the stock has ranged between $0.00 and $0.05, and currently trades 60.0% below its 52-week high.

On profitability, Acrux Limited generates a return on equity (ROE) of -211.88%, return on capital employed of -193.97%, an operating margin of -185.41%, a net profit margin of -83.81%.

Official website: www.acrux.com.au

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides